Connect Education Workshop Details
Help
Treatment Update on Gastrointestinal Stromal Tumors (GIST)
- Overview of GIST
- Current Standard of Care
- New Treatment Approaches
- Clinical Trials
- Pain and Symptom Management
- Communicating with Your Health Care Team
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
George D. Demetri, MD Director, Ludwig Center at Dana-Farber/Harvard and Sarcoma Center, Dana-Farber Cancer Institute |
|
Michael C. Heinrich, MD Professor of Medicine and Cell and Developmental Biology, Interim Head, Hematology and Medical Oncology, Oregon Health & Science University, Section Chief, Hematology and Medical Oncology, Portland VAMC |
|
Jeffrey D. Wayne, MD Assistant Professor of Surgery, Division of Gastrointestinal and Oncologic Surgery, Northwestern University Feinberg School of Medicine, Associate Medical Director, Robert H. Lurie Comprehensive Cancer Center |
|
Keith Lyons, MSW Program Coordinator for Gastrointestinal Cancers, CancerCare |
|
American Cancer Society, American Pain Foundation, American Society of Clinical Oncology, Association of Clinicians for the Underserved, Association of Oncology Social Work, Black Women's Health Imperative, Cancer Patient Education Network, Education Network to Advance Cancer Clinical Trials, Gilda's Club Worldwide, GIST Cancer Research Fund, GIST Support International, Intercultural Cancer Council, Life Raft Group, Multinational Association of Supportive Care in Cancer, National Center for Frontier Communities, National Coalition for Cancer Survivorship, National Family Caregivers Association, Research Advocacy Network, Vital Options International & The Group Room, The Wellness Community
This program is made possible by an educational grant from Pfizer Oncology.
March 3, 2009
